Unconventional methods in the treatment of abnormal uterine bleeding in girls

December 21, 2021
679
Resume

The aim of the study: to study the clinical effectiveness of the homeopathic drug Calcium Quercus Globuli velati in the treatment of adolescent girls with abnormal uterine bleeding (AUB) to achieve hemostasis and the formation of the menstrual cycle (MC).

Object and methods of research. 32 girls aged 12–18 were examined. The control group consisted of 14 girls who received symptomatic therapy. Patients of the main group (n=18) received drug Calcium Quercus Globuli velati with symptomatic therapy homeopathic.

Results. The effectiveness of therapeutic treatment with the use of Calcium Quercus Globuli velati to normalize the MC reached 83%. In girls of the control group who did not receive homeopathic drug, normalization of MC during this period occurred in 67% of cases.

Conclusions.
1. The use of the homeopathic drug Calcium Quercus Globuli velati in adolescent girls with AUB for hemostatic purposes is inappropriate due to the lack of rapid effect.
2. The appointment of this homeopathic drug is appropriate for the formation of MC in girls, because in 55% of patients its use for 3–4 months leads to normalization of MC and the disappearance of pathological changes in the ovaries.
3. An additional criterion for prescribing the drug is heavy menstrual bleeding and a history of allergic skin reactions on the background of its dryness.
4. The use of this drug in the AUB is the method of choice in patients with contraindications to treatment with hormonal drugs.

Reference

  • 1. Vovk I.B., Yuzko O.M., Vdovichenko Yu.P. (Eds.) (2011) Gynecology of children and adolescents. VSV “Medicine”, Kyiv, 424 p.
  • 2. Gurkin Yu.A. (2009) Pediatric and Adolescent Gynecology: A Guide for Physicians. LLC Medical Information Agency, Moscow, 696 p.
  • 3. Levenets S.A., Dynnik V.A., Nachetova T.A. (2012) Menstrual dysfunction in adolescent girls. Kharkov, 196 p.
  • 4. Order of the Ministry of Health of Ukraine № 582 of 15.12.2003 “On approval of clinical protocols for obstetric and gynecological care. Pubertal uterine bleeding.
  • 5. Mykhailyuta M.A., Kirichenko Yu.A., Manashchuk S.I., Kolodynska O.V. (2016) Experience in the treatment and prevention of pubertal uterine bleeding. Obstetrics. Gynecology. Genetics, 1: 44–48.
  • 6. Gleeson N., Buggy F., Sheppard B.L. (1994) The effect of tranecsamic acid on measured menstrual loss and endometrial fibrinilytic enzymes in dysfunctional uterine bleeding. Acta Obstet.Gynecol. Scand., 73: 224–277.
  • 7. Tatarchuk T.F., Kosey N.A., Redko N.A., Dzhupin V.L. (2014) Modern diagnosis and treatment of abnormal uterine bleeding. Reproductive Endocrinology, 15 (19): 22–32.
  • 8. Order of the Ministry of Health of Ukraine dated 13.04.2016 № 353 «On approval of the Unified clinical protocol of primary, secondary (specialized) and tertiary (highly specialized) medical care «Abnormal uterine bleeding».
  • 9. Uvarova E.V. (2013) Abnormal uterine bleeding during puberty. Reproductive health of children and adolescents, 3: 67–72.